Worldwide Clinical Trials Founder Neal Cutler, M.D., Honored with 2017 European CEO Award

Dr. Cutler recognized as “Best CEO in the CRO Industry,” for his leadership in pivotal clinical trials and success as a clinical researcher

Loading media player...

https://www.worldwide.com/

???pagination.previous??? ???pagination.next???

MORRISVILLE, N.C.--()--Neal Cutler, M.D., Chief Executive Officer of Worldwide Clinical Trials (www.worldwide.com), has been named by the 2017 European CEO Awards as the “Best CEO in the CRO Industry.” This honor recognizes Dr. Cutler’s contributions as the founder and CEO of Worldwide, one of the world’s leading, full-service contract research organizations (CROs). The annual European CEO Awards highlight the achievements of CEOs across a variety of industries whose contributions are driving their companies forward.

Dr. Cutler, a board-certified psychiatrist who is also board-qualified in both neurology and clinical pharmacology, has been instrumental in the design and clinical development of nearly 200 compounds in numerous therapeutic areas. Since creating the first iteration of Worldwide Clinical Trials 30 years ago, he has guided the company with a steadfast commitment to the medicine and science of clinical research, leading to impressive growth. This, along with his consistent dedication to Worldwide’s customers, were named as key reasons for his receiving the European CEO Award.

“I am humbled to have been recognized with this prestigious honor. This truly is a reflection of what Worldwide has achieved, and the high-quality service that we consistently deliver – I share this award with our amazing team,” said Dr. Cutler. “My passion for the potentially life-changing work Worldwide does every day drives me and shapes my leadership, and it is this passion that I share with our entire company. This drive to support our sponsor partners in drug discovery permeates our company and has helped build our reputation as one of the world’s leading CROs.”

Throughout his career, Dr. Cutler has been a prominent figure in the industry, having been invited to give hundreds of presentations around the world in the fields of aging, clinical pharmacology and drug development. Additionally, he has authored 276 publications, including nine books on the topics of clinical pharmacology, aging, Alzheimer’s disease, schizophrenia, anxiety disorders and diabetes.

The European CEO Awards recognize the leading players across a range of sectors, the companies pushing the envelope in business, and the executives who make this progress possible. Dr. Cutler joins other recent healthcare industry winners including the CEOs of Chronos Therapeutics, Biolingus, and Evaxion Biotech. For more information, visit www.europeanceo.com/awards/.

Connect with Worldwide Clinical Trials:

About Worldwide Clinical Trials

Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world’s leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders, and rare diseases. For more information, visit Worldwide.com.

Contacts

For Worldwide Clinical Trials
Joel Chesterton
+ 44 (0)1606 889 194
joel@discovery-pr.com

Release Summary

Dr. Cutler recognized as “Best CEO in the CRO Industry,” for his leadership in pivotal clinical trials and success as a clinical researcher

Contacts

For Worldwide Clinical Trials
Joel Chesterton
+ 44 (0)1606 889 194
joel@discovery-pr.com